Squeezing IVDs won’t make the system work any better
This article was originally published in Clinica
Executive Summary
Annual sales of IVDs by the member companies of BIVDA, the British In Vitro Diagnostics Association, fell for the first time in 2013. It wasn’t a large fall and domestic sales still hover around the £700m ($1.2bn) mark (NHS and private), only on a slightly downward trend.